Neumora Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Neumora Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Neumora Therapeutics Inc.
Rating: 1.34950
Author: Trendlyne DVM scores

about

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pip...

1.73 -0.03 (-1.70%)

89.94% Fall from 52W High

236.4K

XNAS Volume

XNAS 29 Aug, 2025 4:02 PM (EDT)

Not Eligible

Expensive Valuation

11.5 / 100

Technically Neutral

42.5 / 100

No estimates available

Neumora Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neumora Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pip...

89.94% Fall from 52W High

SWOT Analysis

Neumora Therapeutics Inc. Live Price Chart